Header cover image

Canadian Pharmaceuticals & Biotech Buy the Dip

Results

1

1 new

Companies which have seen a dip in the last 7 days after continued gains and are looking undervalued based on Snowflake checks.

1 companies

Satellos Bioscience

Market Cap: CA$256.0m

A clinical-stage drug development company, focuses on restoring natural muscle repair and regeneration in degenerative muscle diseases in Canada, the United States, and Australia.

New

MSCL

CA$12.29

7D

-9.2%

1Y

73.6%